Harmony Biosciences Holdings, Inc. (HRMY) Analyst Forecast

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$27.39
Day's range
$28.61

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
02/11/2026 UBS Youn Shim $46.00 $37.93   21.28%
11/24/2025 Oppenheimer Andreas Argyrides $62.00 $34.31   80.71%
07/10/2025 Goldman Sachs Corinne Johnson $33.00 $34.33   -3.87%
10/30/2024 Goldman Sachs Corinne Jenkins $28.00 $41.49   -32.51%
10/10/2024 Mizuho Securities Graig Suvannavejh $52.00 $33.60   54.76%
09/10/2024 UBS Ashwani Verma $56.00 $36.89   51.8%
08/08/2024 Mizuho Securities Graig Suvannavejh $42.00 $33.55   25.19%
06/24/2024 Oppenheimer Francois Brisebois $56.00 $30.39   84.27%
05/01/2024 Needham Ami Fadia $52.00 $30.37   71.22%
04/30/2024 Raymond James Danielle Brill $37.00 $30.91   19.7%
10/14/2022 Jefferies Chris Howerton $61.00 $47.63   28.07%

Harmony Biosciences Holdings Inc FAQ's

Harmony Biosciences Holdings Inc has been rated by research analysts at Deutsche Bank, Mizuho Securities, UBS, Truist Financial, Oppenheimer, H.C. Wainwright in the past 90 days.